IMMUNOGENE ZUSAMMENSETZUNGEN FÜR STREPTOCOCCUS AGALACTIAE

European patent · EP1663303 · Deleted

Register entry

Publication number
EP1663303
Application number
EP04784029
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Sep 15, 2004
Published
Jun 7, 2006
Granted
May 4, 2011
Deleted
Sep 30, 2016
Reason
Annual fee unpaid
IPC classes
A61K 39/385 (2006.01)
A61K 39/116 (2006.01)
A61K 39/00 (2006.01)
A61K 39/02 (2006.01)
A61K 39/38 (2006.01)
A61K 39/09 (2006.01)
Priority
WO PCT/US03/29167 15.09.2003
US 548789 P 26.02.2004
PCT application
PCT/US2004/030032 15.09.2004
PCT publication
WO2005/028618 31.03.2005
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 19, 2017

    Deleted, fee unpaid

    Published in Swissreg on 19.04.2017

  2. Jun 25, 2011

    Agent entered

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in Swissreg on 25.06.2011

  3. May 4, 2011

    Granted

    Published in Swissreg on 04.05.2011

Parties

Holder

Novartis Vaccines and Diagnostics, Inc.

4560 Horton Street, Emeryville, CA 94608-2916, US

Agent

E. Blum & Co. AG

E. Blum & Co. AG Patent- und Markenanwälte VSP

Vorderberg 11, 8044 Zürich

Inventor

Telford, John L. Novartis Vaccines & Diagnostics, SRL

53100 Siena, IT

Grandi, Guido Novartis Vaccines & Diagnostics, SRL

53100 Siena, IT

Margarit Y Ros, Immaculada Novartis Vaccines & Diagnostics, SRL

53100 Siena, IT

Maione, Domenico Novartis Vaccines & Diagnostics, SRL

53100 Siena, IT

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.